Long-Term Efficacy and Safety of Rituximab Versus Tacrolimus in Children With Steroid Dependent Nephrotic Syndrome

INTRODUCTION: In the Rituximab for Relapse Prevention in Nephrotic Syndrome (RITURNS) trial, we demonstrated superior efficacy of single-course rituximab over maintenance tacrolimus in preventing relapses in children with steroid dependent nephrotic syndrome (SDNS) during a 1-year observation. Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Basu, Biswanath, Erdmann, Stella, Sander, Anja, Mahapatra, Tapan Kumar Sinha, Meis, Jan, Schaefer, Franz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403658/
https://www.ncbi.nlm.nih.gov/pubmed/37547526
http://dx.doi.org/10.1016/j.ekir.2023.05.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403658/
https://www.ncbi.nlm.nih.gov/pubmed/37547526
http://dx.doi.org/10.1016/j.ekir.2023.05.022

Ejemplares similares